Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | CHRM5 | P08912 | 6/20 | 0.47 |
| ▸ | CHRM1 | P11229 | 6/20 | 0.47 |
| ▸ | CHRM3 | P20309 | 6/20 | 0.47 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.44 |
| ▸ | CHRM4 | P08173 | 5/20 | 0.44 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.44 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.44 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | HTR1A | P08908 | 2/20 | 0.44 |
| ▸ | PGR | P06401 | 1/20 | 0.44 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.44 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.44 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.44 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.44 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.44 |
| ▸ | GALR3 | O60755 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Triethyl Phosphate SCHEMBL7896685 | 0.89 | CHRM5 (0.49) | THRBCHRM5CHRM1CHRM3CHRM2 | |
| SCHEMBL6462016 | 0.88 | THRB (0.45) | THRBCHRM5CHRM1CHRM3CHRM2 | |
| Phosphoric Acid SCHEMBL386469 | 0.87 | CHRM5 (0.57) | THRBCHRM5CHRM1CHRM3CHRM2 | |
| SCHEMBL3457975 | 0.87 | THRB (0.46) | THRBCHRM5CHRM1CHRM3CHRM2 | |
| Phosphorylethanolamine SCHEMBL27950823 | 0.85 | CHRM5 (0.45) | THRBCHRM5CHRM1CHRM3CHRM2 | |
| SCHEMBL5145800 | 0.84 | THRB (0.42) | THRBTSHR | |
| Phosphocholine SCHEMBL28111186 | 0.84 | TSHR (0.54) | THRBCHRM5CHRM1CHRM3TSHR | |
| Phosphoric Acid SCHEMBL9619842 | 0.84 | CHRM5 (0.53) | THRBCHRM5CHRM1CHRM3CHRM2 | |
| SCHEMBL29199920 | 0.84 | THRB (0.58) | THRBTSHRAPEX1 | |
| Phosphocholine SCHEMBL15862263 | 0.84 | CHRM5 (0.42) | THRBCHRM5CHRM1CHRM3CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9765213-B2 | Drug carriers comprising amphilphilic block copolymers | BIOCOMPATIBLES UK LIMITED (GB) | 2017-09-19 | — | — | US | claimed |
| US-20160089445-A1 | DERIVATISATION OF BIOLOGICAL MOLECULES | BIOCOMPATIBLES UK LIMITED (GB) | 2016-03-31 | — | — | US | claimed |
| US-20140030210-A1 | DERIVATISATION OF BIOLOGICAL MOLECULES | BIOCOMPATIBLES UK LIMITED (GB) | 2014-01-30 | — | — | US | claimed |
| EP-1480619-B1 | DRUG CARRIERS COMPRISING AMPHIPHILIC BLOCK COPOLYMERS | BIOCOMPATIBLES UK LTD (GB) | 2013-08-07 | — | — | EP | claimed |
| US-8431113-B2 | Polymer conjugates | BIOCOMPATIBLES UK LIMITED (GB) | 2013-04-30 | — | — | US | claimed |
| US-20120157550-A1 | DRUG CARRIERS COMPRISING AMPHILPHILIC BLOCK COPOLYMERS | BIOCOMPATIBLES UK LIMITED (GB) | 2012-06-21 | — | — | US | claimed |
| US-8182802-B2 | Cationic block polymers containing 2-methacyloyloxyethyl-2,1-trimethyl ammonium ethyl phosphate liner salt with DNA; drug delivery | BIOCOMPATIBLES UK LIMITED (GB) | 2012-05-22 | — | — | US | claimed |
| US-20120016085-A1 | POLYMER CONJUGATES | BIOCOMPATIBLES UK LIMITED (GB) | 2012-01-19 | — | — | US | claimed |
| US-8048408-B2 | addition polymerization of zwitterionic monomers, under molecular weight control, to form polymers having low polydispersity, used for drug delivery | BIOCOMPATIBLES UK LIMITED (GB) | 2011-11-01 | — | — | US | claimed |
| EP-1480680-B1 | BLOCK COPOLYMERS COMPLEXED WITH NUCLEIC ACIDS | BIOCOMPATIBLES UK LTD (GB) | 2010-11-03 | — | — | EP | claimed |
| US-6852816-B2 | Zwitterionic polymers | BIOCOMPATIBLES UK LIMITED (GB) | 2005-02-08 | — | — | US | claimed |
| EP-1480680-A2 | COMPOSITIONS OF POLYMERS | Biocompatibles UK Limited (GB) | 2004-12-01 | — | — | EP | claimed |
| EP-1480619-A1 | DRUG CARRIERS COMPRISING AMPHIPHILIC BLOCK COPOLYMERS | Biocompatibles UK Limited (GB) | 2004-12-01 | — | — | EP | claimed |
| EP-1465933-A1 | POLYMER CONJUGATES | Biocompatibles UK Limited (GB) | 2004-10-13 | — | — | EP | claimed |
| US-20040063881-A1 | Zwitterionic polymers | BIOCOMPATIBLES UK LIMITED (GB) | 2004-04-01 | — | — | US | claimed |
| WO-2003074090-A2 | COMPOSITIONS OF POLYMERS | BIOCOMPATIBLES UK LIMITED (GB) | 2003-09-12 | — | — | WO | claimed |
| WO-2003074026-A1 | DRUG CARRIERS COMPRISING AMPHIPHILIC BLOCK COPOLYMERS | BIOCOMPATIBLES UK LIMITED (GB) | 2003-09-12 | — | — | WO | claimed |
| WO-2003062290-A1 | POLYMER CONJUGATES | BIOCOMPATIBLES UK LIMITED (GB) | 2003-07-31 | — | — | WO | claimed |
| EP-1325046-A1 | ZWITTERIONIC POLYMERS | Biocompatibles UK Limited (GB) | 2003-07-09 | — | — | EP | claimed |
| WO-2002028929-A1 | ZWITTERIONIC POLYMERS | BIOCOMPATIBLES UK LIMITED (GB) | 2002-04-11 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160089445-A1 | DERIVATISATION OF BIOLOGICAL MOLECULES | IFNG, IFNAR1, IL2 | THRB 4097/4885CHRM5 4548/4885CHRM1 4131/4885 |
| US-20120157550-A1 | DRUG CARRIERS COMPRISING AMPHILPHILIC BLOCK COPOLYMERS | PHOSPHO1, PLA2G2C, ABHD16A | THRB 2112/4885CHRM5 1087/4885CHRM1 410/4885 |
| US-20140030210-A1 | DERIVATISATION OF BIOLOGICAL MOLECULES | IFNG, IFNAR1, IL2 | THRB 4097/4885CHRM5 4548/4885CHRM1 4131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.